Showing results (701-710 of 2,814) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|July 10, 2026
Rebound Hyperglycemia in Children and Adolescents with Type 1 Diabetes Using Automated Insulin Delivery SystemsAjenthen G Ranjan, Katrine G Tidemand, Jannet Svensson, et al.Diabetes Technology & Therapeutics|June 24, 2026
Settings Associated with Optimal Glycemic Outcomes with the Omnipod® 5 Automated Insulin Delivery System: Evidence from Real-World Users with Type 1 DiabetesAlexandra Sawyer, Emma G Wilmot, Duy Do, et al.Diabetes Technology & Therapeutics|January 3, 2023
Maximizing Glycemic Benefits of Using Faster Insulin Formulations in Type 1 Diabetes: In Silico Analysis Under Open- and Closed-Loop ConditionsJenny L Diaz C, Patricio Colmegna, Marc D BretonDiabetes Technology & Therapeutics|July 1, 2026
Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone SensorNicholas Sabelli, Melissa-Rosina Pasqua, Noah Perz, et al.Diabetes Technology & Therapeutics|July 1, 2026
Budget Impact of Advanced Insulin Delivery Systems for the Management of Type 1 DiabetesDanila Fava, Asli Zeynep Ozdemir Saltik, Richard F Pollock, et al.Diabetes Technology & Therapeutics|July 2, 2026
Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry StudyKlemen Dovc, Beata Mianowska, Claudia Boettcher, et al.Diabetes Technology & Therapeutics|July 18, 2026
Three-Year Durability of Automated Insulin Delivery Therapy in Children and Adolescents with Type 1 Diabetes: A Multicenter Real-World StudyBruno Bombaci, Fortunato Lombardo, Marta Bassi, et al.Diabetes Technology & Therapeutics|October 6, 2012
"Symptom-based insulin adjustment for glucose normalization" (SIGN) algorithm: a pilot studyJoyce Yu-Chia Lee, Keith Tsou, Jiahui Lim, et al.Diabetes Technology & Therapeutics|July 15, 2026
Incident Diabetic Retinopathy after Adjunctive Tirzepatide Treatment for 1 Year in Adults with Type 1 DiabetesSarit Polsky, Elizabeth Beck, Archi Shah, et al.Diabetes Technology & Therapeutics|July 17, 2026
Evaluation of an Objective Measure of Mealtime Insulin Administration Frequency in Emerging Adults with Type 1 DiabetesJessica S Pierce, Mark A Clements, Brent Lockee, et al.Pageof 282